3A. Fanning, N. Billo, T. Tannenbaum, et al. Engaging industrialized nations in the challenge to meet global targets. International Journal of Tuberculosis and Lung Disease,2004,7 (4) : 162.
4L. J. Veron, L. J. Blanc, M. Suchi et al. DOTS expansion : will we reach the 2005 targets?. International Journal of Tuberculosis and Lung Disease,2004,7 (2) :41.
5World Health Organization. Global tuberculosis control, WHO report, 2007, Geneva: WHO ,2007.
6T. S. Moulding, H. Q. Le, D. Rikleen, et al. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin. International Journal of Tuberculosis and Lung Disease, 2004,7 (3) : 105 - 106.
7World Health Organization. The global plan to stop tuberculosis ,2006- 2015. Geneva: WHO, 2006.
8Y Balabanova, F Drobniewski, I Fedorin, et al. The Directly observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res,2006,7 ( 1 ) :44.
9Saeed Akhtar, Franklin White, Rumina Hasan, et al. Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan. BMC Public Health,2007,7:70.
10Z. F. Udwadia. The politics, economics and impact of directly observed treatment (DOT) in India. Chronic Respiratory Disease, 2007,4 (2) : 101 - 106.
